WallStreetZenWallStreetZen

NASDAQ: TNYA
Tenaya Therapeutics Inc Stock Ownership - Who owns Tenaya Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tenaya Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Whittemore TingleyChief Medical Officer2025-05-162,937$0.44
$1.30kSell
Faraz AliChief Executive Officer2025-05-163,189$0.44
$1.41kSell
Tomohiro HigaSVP Finance2025-05-161,390$0.44
$615.77Sell
Faraz AliChief Executive Officer2025-03-103,947$0.54
$2.12kSell
Whittemore TingleyChief Medical Officer2025-03-101,598$0.54
$859.72Sell
Tomohiro HigaSVP Finance2025-03-101,017$0.54
$547.15Sell
Tomohiro HigaSVP Finance2025-03-10620$0.54
$333.56Sell
Tomohiro HigaSVP Finance2025-03-10845$0.54
$454.61Sell
Whittemore TingleyChief Medical Officer2025-03-101,727$0.54
$929.13Sell
Whittemore TingleyChief Medical Officer2025-03-104,073$0.54
$2.19kSell

1 of 3

TNYA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TNYA insiders and whales buy or sell their stock.

TNYA Shareholders

What type of owners hold Tenaya Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Column Group III GP LP9.13%14,855,844$8.96MInsider
David V. Goeddel9.13%14,855,844$8.96MInsider
Column Group LLC5.78%9,400,290$5.67MInstitution
Casdin Capital LLC4.14%6,732,971$4.06MInstitution
Eli Casdin3.96%6,440,829$3.88MInsider
Woodline Partners LP3.64%5,916,167$3.57MInstitution
Blackrock Inc3.23%5,256,602$3.17MInstitution
Vanguard Group Inc2.51%4,082,032$2.46MInstitution
Jpmorgan Chase Co1.39%2,258,512$1.36MInstitution
Vr Adviser LLC0.96%1,555,556$938.00kInstitution

1 of 3

TNYA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TNYA29.61%23.54%Net BuyingNet Selling
VXRT11.96%54.81%Net BuyingNet Buying
NTHI0.31%91.78%Net BuyingNet Buying
NAUT40.37%59.63%Net BuyingNet Buying
OKYO0.37%99.63%
View Top Biotech Stocks

Tenaya Therapeutics Stock Ownership FAQ

Who owns Tenaya Therapeutics?

Tenaya Therapeutics (NASDAQ: TNYA) is owned by 29.61% institutional shareholders, 23.54% Tenaya Therapeutics insiders, and 46.84% retail investors. Column Group III GP LP is the largest individual Tenaya Therapeutics shareholder, owning 14.86M shares representing 9.13% of the company. Column Group III GP LP's Tenaya Therapeutics shares are currently valued at $9.11M.

If you're new to stock investing, here's how to buy Tenaya Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.